Daiichi Sankyo is a global pharmaceutical company headquartered in Japan, specializing in innovative medicines for cardiovascular diseases, oncology, and rare diseases. With a strong R&D focus, the company develops cutting-edge therapies including antibody-drug conjugates and maintains a growing presence in both developed and emerging markets.